This is the authors' abstract. We don't add key points for this paper.
OBJECTIVES: Human carbonic anhydrase I and II (hCAI, II) isoenzymes were purified from human erythrocyte. Kinetic interactions between the enzymes and memantine and donepezil, two different drugs used in Alzheimer's disease (AD) treatment, were investigated. MATERIALS AND METHODS: The purification procedure was composed of preparation of homogenate (or hemolysate) and affinity chromatography on Sepharose 4B-L-tyrosine-sulfanilamide. RESULTS: values of memantine and donepezil against hCAII were 0.045 µM and 3.7 µM, respectively. CONCLUSION: Since the levels of CA isoenzymes are low in patients with AD or in the older population, increasing activities of these isoenzymes are important for these patients. The effect of these drugs used in AD treatment was thought to be caused by positive changes in the levels of carbonic anhydrase isoenzymes.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Esra Dilek (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: